Methodology to develop a geometric modeling process according to collaborative constraints

A product design goes through a Digital Mock-Up which is based on the product geometric model. This latter has an important role in the design project whose exploitation mainly depends on how it has been established (DELPHI Automotive Systems, Delphi met á plat ses arborescences, CADReport no. 192, février, 2004). Furthermore, the growing competitive context hardly encourages firms to implement new working methods like collaborative engineering. However, its implementation in combination with product geometric data generates many problems in terms of project and data management. For this purpose, this article proposes a methodological solution to the problem at hand. Moreover the problem gets complicated as the project progresses. As a result, the detailed design phase becomes critical particularly in the face of this problem. Therefore, the current article focuses on this phase of the product design process through an example.     

Variation management by functional tolerance allocation and manufacturing process selection

The imperfections of the manufacturing process lead to functional characteristics degradation, and therefore product quality. To ensure a certain level of product quality, the synthesis of tolerance (tolerance design) aims to determine the acceptable limits of the characteristics of parts, assemblies... The allocation or synthesis of functional tolerances is an important step in the design process which takes place generally during the detailed design and greatly impacts the design of the manufacturing process, manufacturing and product control. That is why it is important, when functional tolerances are quantified, to take into account their impacts on the manufacturing cost and product quality. These two concepts (manufacturing cost and product quality) are usually considered as conflicting goals. The proposed approach aims to allocate the functional tolerances that provide the best ratio between functional performances and manufacturing cost. It is based on the “Key Characteristics” approach, developed by Boeing coupled with an activities approach. This optimization is carried out by a genetic algorithm. The process selection is performed by a constraint satisfaction algorithm. Finally, the impacts of process choices are assessed with the Monte Carlo simulation which calculates the behavior and quality of the resulting product.     

Longitudinal Tissue Velocity and Deformation Imaging in Inferobasal Left Ventricular Aneurysm

Background: Longitudinal myocardial tissue velocity imaging (TVI) and strain rate imaging (SRI) quantify regional myocardial function. We aimed to measure TVI and SRI indices for inferobasal aneurysmal segments by echocardiography at rest. Method: Sixteen patients with inferobasal left ventricular (LV) aneurysm, LV ejection fraction (EF) ≤50%, and 14 normal coronaries with normal echocardiography (control group) were studied. In SRI, peak systolic strain (ST), strain rate (SR), and pattern of strain curves and in TVI, peak systolic inward motion (Sm) were evaluated all at rest. Ascending curve means systolic expansion and descending means shortening. Results: LVEF was significantly lower in the patient group. Mean ST, SR, and Sm of inferobasal segment showed significant difference between patient and control groups; for ST: 1.45 ± 7.18% versus ?17.64 ± 7.45%, P < 0.0001; SR: ?0.25 ± 0.26 versus ?1.44 ± 0.64 sec^?1, P < 0.0001; and Sm: 3.85 ± 1.26 versus 5.56 ± 1.28 cm/sec, P = 0.006, respectively. All inferobasal aneurysmal segments had ascending curve while normal segments showed a descending curve. In patient group, aneurysmal segments had significantly reduced ST and SR compared to normal segments. Normal functioning segments of patients showed significant reduction of ST and SR compared to normal LV segments in control subjects. The range of SR and ST for inferobasal aneurysmal segments did not overlap with that of the normal segments (?0.60, 0.19 and ?3.00, ?0.80 sec^?1 for SR, and ?8.30, 23.30 and ?35.30, ?10.00% for ST, respectively). Conclusion: SRI indices were significantly reduced in inferobasal aneurysmal segment in comparison with either the same segment in normal subjects or normal functioning segments in the same patients. SR and ST may be superior to Sm in the evaluation of inferobasal aneurysmal segments. (Echocardiography 2010;27:803‐808)     

Docosahexaenoic acid prevents resistance to antiepileptic drugs in two animal models of drug-resistant epilepsy

Objectives: One-third of epileptic patients are resistant to antiepileptic drugs. Few clinical studies with small sample size indicate that polyunsaturated fatty acids could control drug-resistant epilepsy. We examined the efficacy of acute and chronic administration of docosahexaenoic acid (DHA) in two animal models of drug-resistant epilepsies, i.e. 6-Hz psychomotor seizures in mice and lamotrigine (LTG)-resistant kindled rats.

Methods: Mice received a single injection of DHA (300?µM, i.c.v.) along with phenytoin (PHT) or LTG (i.p.). Six-Hz electroshock (0.2?milliseconds rectangular pulse width, 3?seconds duration, 44?mA current) was given 15 minutes after DHA, and seizure behaviors were recorded. In LTG-resistant kindled rats, a single dose of DHA (300?µM, i.c.v.) was administered with LTG, and seizure parameters were measured. In chronic treatment, mice received DHA (0.1?g/day, orally) for 30 days. Then, a single dose of LTG or PHT was administered to mice and 6-Hz-induced seizures were recorded. In rats, DHA (1?µM, i.c.v.) was administered during kindling development and effect of LTG in DHA-pretreated LTG-resistant kindled rats was verified.

Results: LTG and PHT did not inhibit 6-Hz seizures in mice after single injection of DHA. However, LTG and PHT inhibited 6-Hz seizures in mice that received DHA for 1?month. Acute or chronic administration of DHA to LTG-resistant kindled rats led to the suppression of kindled seizure parameters by LTG.

Discussion: DHA removes the ‘inherent resistance’ of 6-Hz seizures to PHT and LTG, and prevents the development of pharmacodynamic tolerance to LTG in LTG-resistant kindled rats. DHA might have potential to be used as add-on therapy in patients with refractory epilepsy.